|
ES2032831T5
(es)
*
|
1986-08-19 |
2001-02-16 |
Genentech Inc |
Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas.
|
|
US6565841B1
(en)
*
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
|
DE69332105T2
(de)
*
|
1992-09-29 |
2003-03-06 |
Inhale Therapeutic Systems, San Carlos |
Pulmonale abgabe von aktiven fragmenten des parathormons
|
|
US6012450A
(en)
*
|
1993-01-29 |
2000-01-11 |
Aradigm Corporation |
Intrapulmonary delivery of hematopoietic drug
|
|
US5354934A
(en)
*
|
1993-02-04 |
1994-10-11 |
Amgen Inc. |
Pulmonary administration of erythropoietin
|
|
EP0682526B1
(en)
|
1993-02-12 |
2002-09-04 |
Avant Immunotherapeutics, Inc. |
PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1
|
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
|
US5830853A
(en)
*
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
|
JPH09509828A
(ja)
*
|
1994-03-04 |
1997-10-07 |
ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ |
標的遺伝子損傷をした動物
|
|
MX9603936A
(es)
*
|
1994-03-07 |
1997-05-31 |
Inhale Therapeutic Syst |
Metodos y composiciones para el suministro pulmonar de insulina.
|
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
|
JPH10500672A
(ja)
*
|
1994-05-18 |
1998-01-20 |
インヘイル セラピューティック システムズ，インコーポレイティド |
インターフェロンの乾燥粉末製剤に関する方法及び組成物
|
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
|
PT806945E
(pt)
|
1994-12-22 |
2003-09-30 |
Astrazeneca Ab |
Preparacao terapeutica para inalacao que contem a hormona paratiroide, hpt
|
|
CN1088580C
(zh)
|
1994-12-22 |
2002-08-07 |
阿斯特拉公司 |
气溶胶药物制剂
|
|
WO1996030068A1
(en)
*
|
1995-03-31 |
1996-10-03 |
Aradigm Corporation |
Intrapulmonary delivery of hematopoietic drug
|
|
US20030040467A1
(en)
*
|
1998-06-15 |
2003-02-27 |
Mary Ann Pelleymounter |
Ig/ob fusions and uses thereof.
|
|
US6936439B2
(en)
*
|
1995-11-22 |
2005-08-30 |
Amgen Inc. |
OB fusion protein compositions and methods
|
|
CA2275889C
(en)
|
1996-12-30 |
2008-03-18 |
Battelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
|
DE19733651A1
(de)
*
|
1997-08-04 |
1999-02-18 |
Boehringer Ingelheim Pharma |
Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
|
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
AU750567B2
(en)
†
|
1997-09-29 |
2002-07-25 |
Novartis Ag |
Stabilized preparations for use in nebulizers
|
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6433040B1
(en)
*
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
|
US6858706B2
(en)
|
1998-04-07 |
2005-02-22 |
St. Jude Children's Research Hospital |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
WO2000024770A2
(en)
*
|
1998-10-23 |
2000-05-04 |
Amgen Inc. |
Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
|
|
US6773911B1
(en)
*
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
|
DK1140198T3
(da)
|
1999-01-13 |
2008-03-10 |
Alchemia Oncology Pty Ltd |
Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad
|
|
US6500418B1
(en)
*
|
1999-02-12 |
2002-12-31 |
The Washington University |
Stimulating neutrophil function to treat inflammatory bowel disease
|
|
NZ513935A
(en)
|
1999-02-17 |
2004-02-27 |
Csl Ltd |
Immunogenic complexes and methods relating thereto
|
|
HUP0104688A3
(en)
*
|
1999-09-03 |
2004-07-28 |
Amgen Inc Thousand Oaks |
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
|
|
US6808902B1
(en)
|
1999-11-12 |
2004-10-26 |
Amgen Inc. |
Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
|
|
AU772617B2
(en)
*
|
1999-11-19 |
2004-05-06 |
Csl Limited |
Vaccine compositions
|
|
AU784634B2
(en)
|
1999-11-30 |
2006-05-18 |
Mayo Foundation For Medical Education And Research |
B7-H1, a novel immunoregulatory molecule
|
|
BR0016879A
(pt)
*
|
1999-12-30 |
2002-12-03 |
Chiron Corp |
Métodos para transferência de interleucina-2 por via pulmonar
|
|
US7030219B2
(en)
*
|
2000-04-28 |
2006-04-18 |
Johns Hopkins University |
B7-DC, Dendritic cell co-stimulatory molecules
|
|
US7871598B1
(en)
*
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
AUPQ879500A0
(en)
*
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
|
US9066919B2
(en)
*
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
|
CA2417357A1
(en)
|
2000-08-08 |
2002-02-14 |
St. Jude Children's Research Hospital |
Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
|
|
DK1385882T3
(da)
|
2001-05-11 |
2008-02-11 |
Amgen Inc |
Peptider og relaterede molekyler, der binder til TALL-1
|
|
WO2003018062A1
(en)
*
|
2001-08-27 |
2003-03-06 |
Meditech Research Limited |
Improved therapeutic protocols
|
|
US7332474B2
(en)
*
|
2001-10-11 |
2008-02-19 |
Amgen Inc. |
Peptides and related compounds having thrombopoietic activity
|
|
US6964761B1
(en)
|
2001-12-12 |
2005-11-15 |
New York University |
Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-γ
|
|
US7368102B2
(en)
|
2001-12-19 |
2008-05-06 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
|
WO2003081238A2
(en)
*
|
2002-03-22 |
2003-10-02 |
Ludwig Maximilians Universität |
Cytocapacity test
|
|
US20030191056A1
(en)
|
2002-04-04 |
2003-10-09 |
Kenneth Walker |
Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
|
|
US7388076B2
(en)
*
|
2002-07-16 |
2008-06-17 |
University Of South Florida |
Human immunosuppressive protein
|
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
|
CA2498651C
(en)
|
2002-09-13 |
2011-08-30 |
Universite Laval |
Nucleoside triphosphate diphosphohydrolase and uses thereof
|
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
|
US7432351B1
(en)
|
2002-10-04 |
2008-10-07 |
Mayo Foundation For Medical Education And Research |
B7-H1 variants
|
|
WO2004094457A2
(en)
*
|
2003-04-16 |
2004-11-04 |
Arizona Board Of Regents, Acting For And On Behalf Of, Arizona State University |
Stable rgd peptidomimetic composition
|
|
CN1820024B
(zh)
|
2003-05-12 |
2011-06-22 |
阿费麦克斯公司 |
新的聚(乙二醇)修饰的化合物及其用途
|
|
JP2007500218A
(ja)
|
2003-05-12 |
2007-01-11 |
アフィーマックス・インコーポレイテッド |
ポリ（エチレングリコール）修飾ペプチド系化合物の新規スペーサー部分
|
|
TWI359675B
(en)
*
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
CA2533512C
(en)
|
2003-07-25 |
2013-06-11 |
Amgen Inc. |
Antagonists and agonists of ldcam and methods of use
|
|
US20090226397A1
(en)
|
2003-10-24 |
2009-09-10 |
Nora Therapeutics, Inc. |
Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
|
|
US8338373B2
(en)
*
|
2003-10-24 |
2012-12-25 |
Nora Therapeutics, Inc. |
Method for reducing the risk of spontaneous abortion in a human female subject
|
|
EP1682074B1
(en)
|
2003-10-24 |
2012-02-08 |
Nora Therapeutics, Inc. |
Compositions and methods for healthy pregnancy
|
|
WO2005042024A1
(en)
*
|
2003-11-04 |
2005-05-12 |
Lek Pharmaceuticals D.D. |
Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
|
|
CN1980694B
(zh)
|
2004-05-12 |
2012-09-26 |
布赖汉姆妇女医院有限公司 |
凝溶胶蛋白治疗感染的用途
|
|
JP2008505928A
(ja)
*
|
2004-07-08 |
2008-02-28 |
アムジェン インコーポレーテッド |
治療用ペプチド
|
|
KR20100018029A
(ko)
|
2004-07-18 |
2010-02-16 |
씨에스엘 리미티드 |
면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기 위한 올리고뉴클레오티드 제제
|
|
JP5017116B2
(ja)
*
|
2004-09-24 |
2012-09-05 |
アムジエン・インコーポレーテツド |
修飾Ｆｃ分子
|
|
CA2943949C
(en)
|
2004-10-06 |
2020-03-31 |
Mayo Foundation For Medical Education And Research |
B7-h1 and methods of diagnosis, prognosis, and treatment of cancer
|
|
WO2006060148A2
(en)
*
|
2004-11-11 |
2006-06-08 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
|
US7833979B2
(en)
*
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US7968096B2
(en)
*
|
2005-05-04 |
2011-06-28 |
The University Of Vermont And State Agricultural College |
Methods and compositions for treating toxoplasma
|
|
US7550433B2
(en)
|
2005-06-03 |
2009-06-23 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
|
US8324159B2
(en)
*
|
2005-06-03 |
2012-12-04 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
|
US7919461B2
(en)
*
|
2005-06-03 |
2011-04-05 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
|
ATE530569T1
(de)
|
2005-07-01 |
2011-11-15 |
Forsyth Dental In Ry For Children Fa |
Assays zum nachweis von tuberkulose- antigenen, und impfstoffe
|
|
JP5465431B2
(ja)
*
|
2005-07-27 |
2014-04-09 |
アルケミア オンコロジー ピーティーワイ リミテッド |
ヒアルロナンを用いる治療プロトコル
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
EP1922077A4
(en)
*
|
2005-09-07 |
2013-03-06 |
Alchemia Oncology Pty Ltd |
THERAPEUTIC COMPOSITIONS WITH HYALURON AND THERAPEUTIC ANTIBODIES AND TREATMENT PROCEDURES
|
|
CN101321868A
(zh)
*
|
2005-09-16 |
2008-12-10 |
科利制药公司 |
通过核苷酸修饰调节短干扰核糖核酸(siRNA)的免疫刺激特性
|
|
AU2006337419A1
(en)
*
|
2005-09-16 |
2007-08-09 |
Coley Pharmaceutical Gmbh |
Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone
|
|
CA2622987C
(en)
|
2005-09-20 |
2018-02-27 |
New York University |
Method of treating pulmonary disease with interferons
|
|
US8105572B2
(en)
*
|
2007-05-18 |
2012-01-31 |
New York University |
Method of treating tuberculosis with interferons
|
|
DK2388273T3
(en)
|
2005-10-21 |
2017-10-09 |
Lfb Usa Inc |
ANTIBODIES WITH INCREASED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ACTIVITY, PROCEDURES FOR THE PRODUCTION OF THESE AND USE THEREOF
|
|
AR056142A1
(es)
*
|
2005-10-21 |
2007-09-19 |
Amgen Inc |
Metodos para generar el anticuerpo igg monovalente
|
|
TW200736277A
(en)
|
2005-11-14 |
2007-10-01 |
Amgen Inc |
RANKL antibody-PTH/PTHrP chimeric molecules
|
|
US20080052114A1
(en)
*
|
2005-11-30 |
2008-02-28 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational systems and methods related to nutraceuticals
|
|
US7827042B2
(en)
*
|
2005-11-30 |
2010-11-02 |
The Invention Science Fund I, Inc |
Methods and systems related to transmission of nutraceutical associated information
|
|
US8000981B2
(en)
|
2005-11-30 |
2011-08-16 |
The Invention Science Fund I, Llc |
Methods and systems related to receiving nutraceutical associated information
|
|
US20080033763A1
(en)
*
|
2005-11-30 |
2008-02-07 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems related to receiving nutraceutical associated information
|
|
US20070174128A1
(en)
*
|
2005-11-30 |
2007-07-26 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
|
|
US20070289258A1
(en)
*
|
2006-06-14 |
2007-12-20 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Individualized pharmaceutical selection and packaging
|
|
US20070136092A1
(en)
*
|
2005-11-30 |
2007-06-14 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
|
|
US20080114577A1
(en)
*
|
2005-11-30 |
2008-05-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems associated with nutraceutical related assays
|
|
US7974856B2
(en)
|
2005-11-30 |
2011-07-05 |
The Invention Science Fund I, Llc |
Computational systems and methods related to nutraceuticals
|
|
US7927787B2
(en)
*
|
2006-06-28 |
2011-04-19 |
The Invention Science Fund I, Llc |
Methods and systems for analysis of nutraceutical associated components
|
|
US8297028B2
(en)
|
2006-06-14 |
2012-10-30 |
The Invention Science Fund I, Llc |
Individualized pharmaceutical selection and packaging
|
|
US10296720B2
(en)
|
2005-11-30 |
2019-05-21 |
Gearbox Llc |
Computational systems and methods related to nutraceuticals
|
|
US8340944B2
(en)
*
|
2005-11-30 |
2012-12-25 |
The Invention Science Fund I, Llc |
Computational and/or control systems and methods related to nutraceutical agent selection and dosing
|
|
US20070124218A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized nutraceutical selection and packaging
|
|
US20070124176A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems and methods related to nutraceutical agent selection and dosing
|
|
US20080004905A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems for analysis of nutraceutical associated components
|
|
US8068991B2
(en)
*
|
2005-11-30 |
2011-11-29 |
The Invention Science Fund I, Llc |
Systems and methods for transmitting pathogen related information and responding
|
|
US20110145009A1
(en)
*
|
2005-11-30 |
2011-06-16 |
Jung Edward K Y |
Methods and systems related to transmission of nutraceutical associatd information
|
|
US20090215084A1
(en)
*
|
2006-01-05 |
2009-08-27 |
Mayo Foundation For Medical Education And Research |
B7-h1 and b7-h4 in cancer
|
|
US20100015642A1
(en)
*
|
2006-01-05 |
2010-01-21 |
Kwon Eugene D |
B7-h1 and survivin in cancer
|
|
US20080044405A1
(en)
*
|
2006-02-25 |
2008-02-21 |
President And Fellows Of Harvard College |
Noble metal complex-mediated immunosuppression
|
|
WO2007109056A2
(en)
|
2006-03-15 |
2007-09-27 |
The Brigham And Women's Hospital, Inc. |
Use of gelsolin to diagnose and treat inflammatory diseases
|
|
HUE035980T2
(hu)
|
2006-03-15 |
2018-06-28 |
Brigham & Womens Hospital Inc |
Gelzolin alkalmazása szklerózis multiplex kezelésére és neurológiai betegségek diagnosztizálására
|
|
WO2007124361A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Mayo Foundation For Medical Education And Research |
Soluble b7-h1
|
|
EP2029157A4
(en)
*
|
2006-05-19 |
2009-11-18 |
Georgia Tech Res Inst |
LIGAND OF CARRIERS ABC
|
|
US7981425B2
(en)
*
|
2006-06-19 |
2011-07-19 |
Amgen Inc. |
Thrombopoietic compounds
|
|
CA2787343C
(en)
|
2006-06-26 |
2016-08-02 |
Amgen Inc. |
Compositions comprising modified lcat and uses thereof
|
|
DE102006030164A1
(de)
*
|
2006-06-29 |
2008-01-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Pulver
|
|
EP2049138A4
(en)
*
|
2006-07-14 |
2011-11-09 |
Georgia Tech Res Inst |
CLC KANALLIGAND
|
|
NZ575437A
(en)
|
2006-09-27 |
2012-02-24 |
Coley Pharm Gmbh |
Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
|
|
CA2667678A1
(en)
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
EP2586458B1
(en)
*
|
2006-12-27 |
2016-08-24 |
The Johns Hopkins University |
Compositions and methods for treating inflammation and auto-immune diseases
|
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
|
WO2008116470A1
(en)
*
|
2007-03-26 |
2008-10-02 |
Drugrecure Aps |
Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor
|
|
US8747872B2
(en)
*
|
2007-05-02 |
2014-06-10 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
|
SI2170353T1
(sl)
*
|
2007-05-18 |
2015-09-30 |
Adiu Tide Pharmaceuticals Gmbh |
Fosfatno modificirani oligonukleotidni analogi z imunostimulatorno aktivnostjo
|
|
WO2008143892A1
(en)
*
|
2007-05-18 |
2008-11-27 |
New York University |
Method of treating tuberculosis with interferons
|
|
US8420779B2
(en)
*
|
2007-05-22 |
2013-04-16 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
CA2693707A1
(en)
*
|
2007-07-13 |
2009-03-05 |
The Johns Hopkins University |
B7-dc variants
|
|
PL2489731T3
(pl)
|
2007-07-26 |
2015-01-30 |
Amgen Inc |
Zmodyfikowane enzymy acylotransferaza lecytyna-cholesterol
|
|
EP2471510A1
(de)
*
|
2007-08-27 |
2012-07-04 |
BioGeneriX AG |
Flüssigformulierung von G-CSF
|
|
KR20100068422A
(ko)
*
|
2007-10-09 |
2010-06-23 |
콜리 파마슈티칼 게엠베하 |
변경된 당 잔기를 함유하는 면역자극성 올리고뉴클레오티드 유사체
|
|
CA2704853C
(en)
|
2007-11-06 |
2017-08-15 |
Eugen Uhlmann |
Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
|
|
WO2009075836A2
(en)
*
|
2007-12-10 |
2009-06-18 |
The Brigham And Women's Hospital, Inc. |
Rap variants for drug delivery
|
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
|
PT2708603T
(pt)
|
2008-01-25 |
2017-07-20 |
The Brigham And Women`S Hospital Inc |
Utilizações em diagnóstico e terapia da gelsolina na insuficiência renal
|
|
US20110020325A1
(en)
*
|
2008-02-29 |
2011-01-27 |
Kwon Eugene D |
Methods for reducing granulomatous inflammation
|
|
EP2257301B1
(en)
|
2008-03-03 |
2014-01-22 |
The University of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
EP2274001A4
(en)
|
2008-03-20 |
2012-08-01 |
Univ Miami |
VACCINATION WITH HEAT SHOCK PROTEIN GP96 AND APPLICATION METHOD THEREFOR
|
|
US20110171168A1
(en)
*
|
2008-05-13 |
2011-07-14 |
Nora Therapeutics, Inc. |
Human g-csf analogs and methods of making and using thereof
|
|
US20100075926A1
(en)
*
|
2008-07-23 |
2010-03-25 |
Li-Huei Tsai |
Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
|
|
CN102105594A
(zh)
*
|
2008-07-30 |
2011-06-22 |
达纳-法伯癌症研究所有限公司 |
用于检测细胞死亡的组合物和其使用方法
|
|
US10457639B2
(en)
|
2008-08-15 |
2019-10-29 |
Georgetown University |
Fluorescent regulators of RASSF1A expression and human cancer cell proliferation
|
|
UA104148C2
(ru)
|
2008-08-22 |
2014-01-10 |
Санофі-Авентіс |
[4-(5-аминометил-2-фторфенил)-пиперидин-1-ил]-[7-фтор-1-(2-метоксиэтил)-4-трифторметокси-1h-индол-3-ил]-метанон как ингибитор триптазы тучных клеток
|
|
JP2012500855A
(ja)
*
|
2008-08-25 |
2012-01-12 |
アンプリミューン、インコーポレーテッド |
Ｐｄ−１アンタゴニストおよび感染性疾患を処置するための方法
|
|
ES2545609T3
(es)
|
2008-08-25 |
2015-09-14 |
Amplimmune, Inc. |
Composiciones de antagonistas de PD-1 y métodos de uso
|
|
CN108165548B
(zh)
|
2008-09-22 |
2022-10-14 |
菲奥医药公司 |
减小大小的自递送RNAi化合物
|
|
CN102223876A
(zh)
*
|
2008-09-26 |
2011-10-19 |
纳米生物公司 |
纳米乳剂治疗性组合物及其使用方法
|
|
KR101700972B1
(ko)
*
|
2008-10-21 |
2017-01-31 |
국제백신연구소 |
신규한 시겔라 단백질 항원 및 방법
|
|
CA2743502A1
(en)
|
2008-11-13 |
2010-05-20 |
Instituto De Medicina Molecular |
Foxp3+ natural killer t-cells and the treatment of immune related diseases
|
|
US9974844B2
(en)
|
2008-11-17 |
2018-05-22 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
|
WO2010068680A1
(en)
|
2008-12-10 |
2010-06-17 |
Mount Sinai School Of Medicine Of New York University |
Thelper cell type 17 lineage-specific adjuvants, compositions and methods
|
|
AR074776A1
(es)
|
2008-12-18 |
2011-02-09 |
Sanofi Aventis |
Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
|
|
US9745574B2
(en)
|
2009-02-04 |
2017-08-29 |
Rxi Pharmaceuticals Corporation |
RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
|
EP2662472B1
(de)
|
2009-03-31 |
2019-02-27 |
Boehringer Ingelheim International Gmbh |
Verfahren zur Beschichtung einer Oberfläche eines Bauteils
|
|
WO2010133294A2
(de)
|
2009-05-18 |
2010-11-25 |
Boehringer Ingelheim International Gmbh |
Adapter, inhalationseinrichtung und zerstäuber
|
|
EP3020412B1
(en)
|
2009-06-16 |
2017-10-11 |
The Regents of the University of Michigan |
An immunogenic composition comprising nanoemulsion inactivated rsv
|
|
US8232318B2
(en)
|
2009-07-31 |
2012-07-31 |
The General Hospital Corporation |
Approaches to treat cancer using HB-EGF inhibitors
|
|
CN102770455B
(zh)
|
2009-08-03 |
2017-02-08 |
迈阿密大学 |
用于体内扩增调节性t细胞的方法
|
|
FR2955324A1
(fr)
|
2010-01-15 |
2011-07-22 |
Sanofi Aventis |
[4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones disubstituees
|
|
JP2013503205A
(ja)
|
2009-08-31 |
2013-01-31 |
アンプリミューン， インコーポレイテッド |
移植拒絶反応を阻害するための方法および組成物
|
|
WO2011053468A1
(en)
|
2009-10-30 |
2011-05-05 |
Sanofi-Aventis |
Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders
|
|
MX2012005961A
(es)
|
2009-11-25 |
2012-06-14 |
Boehringer Ingelheim Int |
Nebulizador.
|
|
EP2504051B1
(en)
|
2009-11-25 |
2019-09-04 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
|
MX2012007080A
(es)
|
2009-12-23 |
2012-07-20 |
Sanofi Sa |
[4[4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(1h-pirrolo-pi ri-din-il)-metanonas y sintesis de las mismas.
|
|
BR112012014860A2
(pt)
|
2009-12-23 |
2016-03-29 |
Sanofi Sa |
pró-fármacos de [4 [4-(5-aminometil-2-flúor-fenil)-piperidin-1-il]-(1h-pirrolo-piridin-il)-metanonas e sua síntese
|
|
US9080171B2
(en)
|
2010-03-24 |
2015-07-14 |
RXi Parmaceuticals Corporation |
Reduced size self-delivering RNAi compounds
|
|
US8658603B2
(en)
|
2010-06-16 |
2014-02-25 |
The Regents Of The University Of Michigan |
Compositions and methods for inducing an immune response
|
|
US9943654B2
(en)
|
2010-06-24 |
2018-04-17 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
|
WO2012006506A1
(en)
|
2010-07-09 |
2012-01-12 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
|
PE20140593A1
(es)
|
2011-03-16 |
2014-05-10 |
Amgen Inc |
Inhibidores potentes y selectivos de nav1.3 y nav1.7
|
|
US9181308B2
(en)
|
2011-03-28 |
2015-11-10 |
St. Jude Children's Research Hospital |
Methods and compositions employing immunogenic fusion proteins
|
|
EP2694220B1
(de)
|
2011-04-01 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Medizinisches gerät mit behälter
|
|
WO2012149540A1
(en)
|
2011-04-28 |
2012-11-01 |
The Broad Institute Inc |
Inhibitors of histone deacetylase
|
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
|
EP3483150A1
(en)
|
2011-07-22 |
2019-05-15 |
Massachusetts Institute Of Technology |
Activators of class 1 histone deacetylases (hdacs) and uses thereof
|
|
WO2013021279A2
(en)
|
2011-08-10 |
2013-02-14 |
Lfb Biotechnologies |
Highly galactosylated antibodies
|
|
US20130236484A1
(en)
|
2012-03-08 |
2013-09-12 |
Detectogen Inc. |
Leishmaniasis antigen detection assays and vaccines
|
|
TW201400499A
(zh)
|
2012-03-12 |
2014-01-01 |
Revo Biolog Inc |
抗凝血酶用於治療妊娠毒血症之用途
|
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
|
US9914717B2
(en)
|
2012-12-20 |
2018-03-13 |
The Broad Institute, Inc. |
Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
|
|
WO2014099984A1
(en)
|
2012-12-20 |
2014-06-26 |
Amgen Inc. |
Apj receptor agonists and uses thereof
|
|
EP2970408B1
(en)
|
2013-03-12 |
2018-01-10 |
Amgen Inc. |
Potent and selective inhibitors of nav1.7
|
|
US9302005B2
(en)
|
2013-03-14 |
2016-04-05 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
US10233219B2
(en)
|
2013-04-12 |
2019-03-19 |
Tufts Medical Center |
Methods and systems for designing and/or characterizing soluble lipidated ligand agents
|
|
EP2835146B1
(en)
|
2013-08-09 |
2020-09-30 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
|
EP3030298B1
(en)
|
2013-08-09 |
2017-10-11 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
|
DK3041958T3
(da)
|
2013-09-04 |
2020-03-09 |
Cold Spring Harbor Laboratory |
Reducering af nonsense-medieret mrna-degradering
|
|
EP3052131B1
(en)
|
2013-10-01 |
2018-12-05 |
Mayo Foundation for Medical Education and Research |
Methods for treating cancer in patients with elevated levels of bim
|
|
WO2015057724A1
(en)
|
2013-10-14 |
2015-04-23 |
Nora Therapeutics, Inc. |
Use of g-csf for treating or preventing villitis of unknown etiology in a human female
|
|
CA2928700C
(en)
|
2013-11-01 |
2019-01-15 |
University Of Oslo |
Albumin variants and uses thereof
|
|
US11452767B2
(en)
|
2013-11-15 |
2022-09-27 |
Oslo Universitetssykehus Hf |
CTL peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
|
|
WO2015167567A1
(en)
|
2014-05-01 |
2015-11-05 |
Charlesson Llc |
Stat3 inhibitors for treatment of hyperglycemia and impaired spatial vision
|
|
JP6745225B2
(ja)
|
2014-05-07 |
2020-08-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
容器、表示デバイス、及びネブライザ
|
|
EA032850B1
(ru)
|
2014-05-07 |
2019-07-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Контейнер, небулайзер и способ изготовления контейнера
|
|
ES2874029T3
(es)
|
2014-05-07 |
2021-11-04 |
Boehringer Ingelheim Int |
Nebulizador
|
|
WO2015179654A1
(en)
|
2014-05-22 |
2015-11-26 |
Mayo Foundation For Medical Education And Research |
Distinguishing antagonistic and agonistic anti b7-h1 antibodies
|
|
EP3155002B1
(en)
|
2014-06-10 |
2019-11-27 |
Amgen Inc. |
Apelin polypeptides
|
|
ES2951596T3
(es)
|
2014-06-13 |
2023-10-23 |
Bach Biosciences Llc |
Agentes terapéuticos activados por FAP y usos relacionados con los mismos
|
|
EP3171896A4
(en)
|
2014-07-23 |
2018-03-21 |
Mayo Foundation for Medical Education and Research |
Targeting dna-pkcs and b7-h1 to treat cancer
|
|
WO2016057921A1
(en)
|
2014-10-10 |
2016-04-14 |
Baker Jr James R |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
|
EP3221299A1
(en)
|
2014-11-21 |
2017-09-27 |
BSIM2 Biomolecular Simulations Lda. |
2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
|
|
PL415073A1
(pl)
|
2014-12-19 |
2016-06-20 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
|
|
PL410665A1
(pl)
|
2014-12-29 |
2016-07-04 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Inhibitory arginazy oraz ich zastosowania terapeutyczne
|
|
AU2016205187B2
(en)
|
2015-01-08 |
2020-02-27 |
The Board Of Trustees Of The University Of Illinois |
Concise synthesis of urea derivatives of amphotericin B
|
|
EP4226937A3
(en)
|
2015-03-05 |
2023-09-27 |
Northwestern University |
Non-neuroinvasive viruses and uses thereof
|
|
PT3283171T
(pt)
|
2015-04-15 |
2021-07-14 |
Sfunga Therapeutics Inc |
Derivados de anfotericina b
|
|
EP3307723B1
(en)
|
2015-06-15 |
2020-11-11 |
BSIM2 - Biomolecular Simulations, S.A. |
Bis-furan derivatives as transthyretin (ttr) stabilizers and amyloid inhibitors for the treatment of familial amyloid polyneuropathy (fap)
|
|
PL415078A1
(pl)
|
2015-09-04 |
2017-03-13 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
|
|
CN109563509B
(zh)
|
2015-10-19 |
2022-08-09 |
菲奥医药公司 |
靶向长非编码rna的减小尺寸的自递送核酸化合物
|
|
WO2017075045A2
(en)
|
2015-10-30 |
2017-05-04 |
Mayo Foundation For Medical Education And Research |
Antibodies to b7-h1
|
|
AU2017210118B2
(en)
|
2016-01-22 |
2023-05-04 |
On Target Therapeutics, LLC. |
Compounds and methods for treating inflammation
|
|
JP7041961B2
(ja)
|
2016-04-08 |
2022-03-25 |
ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ |
ヒト嚢胞性線維症肺上皮における気道表面の生理機能の小分子介在性回復
|
|
PL417066A1
(pl)
|
2016-05-04 |
2017-11-06 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Inhibitory arginazy oraz ich zastosowania terapeutyczne
|
|
WO2018080573A1
(en)
|
2016-10-28 |
2018-05-03 |
Massachusetts Institute Of Technology |
Crispr/cas global regulator screening platform
|
|
WO2018096396A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Oslo |
Albumin variants and uses thereof
|
|
US11318190B2
(en)
|
2017-05-05 |
2022-05-03 |
United States Government As Represented By The Department Of Veterans Affairs |
Methods and compositions for treating liver disease
|
|
EP3678699A1
(en)
|
2017-09-07 |
2020-07-15 |
University Of Oslo |
Vaccine molecules
|
|
JP2020533338A
(ja)
|
2017-09-07 |
2020-11-19 |
ユニバーシティ オブ オスロＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｏｓｌｏ |
ワクチン分子
|
|
PT3694526T
(pt)
|
2017-10-11 |
2025-01-20 |
Univ Illinois |
Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas
|
|
EP3723783B1
(en)
|
2017-12-15 |
2023-02-15 |
Stealth BioTherapeutics Inc. |
Mitochondria-targeting peptides
|
|
US12128018B2
(en)
|
2018-01-12 |
2024-10-29 |
KDAc Therapeutics, Inc. |
Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer
|
|
EP3873540A4
(en)
|
2018-10-31 |
2022-07-27 |
Mayo Foundation for Medical Education and Research |
Methods and materials for treating cancer
|
|
EP3873500A4
(en)
|
2018-10-31 |
2023-01-11 |
Mayo Foundation for Medical Education and Research |
CANCER TREATMENT METHODS AND MATERIALS
|
|
WO2021009209A1
(en)
|
2019-07-15 |
2021-01-21 |
Oncoarendi Therapeutics S.A. |
Substituted amino triazoles useful as chitinase inhibitors
|
|
AU2020316449A1
(en)
|
2019-07-24 |
2022-02-10 |
Stealth Biotherapeutics Inc. |
The peptidomimetic compound (R)-2-amino-N-((S)-L-(((S)-5-amino-L-(3-benzyl-1,2,4-oxadiazol-5-yl)pentyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)-l-oxopropan-2-yl)-5-guanidinopentanamide in the treatment of neurodegenerative diseases
|
|
WO2021067836A1
(en)
|
2019-10-04 |
2021-04-08 |
Stealth Biotherapeutics Corp |
Chinone-, hydrochinome- and naphthochinone-analogues of vatiquione for treatment of mitochondrial disorder diseases
|
|
KR20230005855A
(ko)
|
2020-04-03 |
2023-01-10 |
스텔스 바이오테라퓨틱스 인코포레이티드 |
프리드리히 운동실조를 포함한 미토콘드리아 질환의 예방 및/또는 치료를 위한 조성물 및 방법
|
|
US11572342B2
(en)
|
2020-09-18 |
2023-02-07 |
Niche Biopharmaceuticals LLC |
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
|
|
TW202228720A
(zh)
|
2020-12-22 |
2022-08-01 |
波蘭商昂科艾倫迪治療法股份公司 |
精胺酸酶抑制劑及其使用方法
|
|
US11834408B2
(en)
|
2021-05-28 |
2023-12-05 |
Purdue Research Foundation |
Compounds for the treatment of SARS
|
|
US20240366558A1
(en)
|
2021-08-30 |
2024-11-07 |
Amazentis Sa |
Treating long covid-19 with urolithins
|
|
WO2023069255A1
(en)
|
2021-10-20 |
2023-04-27 |
Stealth Biotherapeutics Inc. |
Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
|
|
WO2023119233A1
(en)
|
2021-12-23 |
2023-06-29 |
Molecure S.A. |
Deubiquitinase inhibitors and methods of use thereof
|
|
JP2025503652A
(ja)
|
2022-01-10 |
2025-02-04 |
ステルス バイオセラピューティクス インコーポレイテッド |
タウオパチーの治療のための小分子ペプチドミメティック
|
|
WO2023154962A1
(en)
|
2022-02-14 |
2023-08-17 |
Subhash Sinha |
Cgas inhibitors and uses thereof
|
|
EP4269400B1
(en)
|
2022-04-29 |
2025-07-09 |
Molecure SA |
Ykl-40 inhibitors and their therapeutic applications
|
|
US20240150362A1
(en)
|
2022-08-25 |
2024-05-09 |
Molecure S.A. |
Substituted Pyrrolotriazines
|
|
EP4622712A1
(en)
|
2022-11-23 |
2025-10-01 |
Vertex Pharmaceuticals Incorporated |
Substituted macrocyclic amine modulators of orexin receptor 2
|
|
WO2024168004A1
(en)
|
2023-02-08 |
2024-08-15 |
Vertex Pharmaceuticals Incorporated |
Biaryl amide-containing agonists of orexin receptor type 2
|
|
WO2025010314A1
(en)
|
2023-07-05 |
2025-01-09 |
Vertex Pharmaceuticals Incorporated |
Urea-containing agonists of orexin receptor type 2
|
|
WO2025010311A1
(en)
|
2023-07-05 |
2025-01-09 |
Vertex Pharmaceuticals Incorporated |
Urea-containing agonists of orexin receptor type 2
|
|
WO2025049985A1
(en)
|
2023-08-31 |
2025-03-06 |
Purdue Research Foundation |
Methods and compositions for the treatment of cancer using an inhibitor of prm t5
|
|
WO2025101748A1
(en)
|
2023-11-09 |
2025-05-15 |
Stealth Biotherapeutics Inc. |
Cyclo-hexa-2,5-diene-1,4-diones for use in the treatment of cardiomyopathy
|